Factors | Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|---|
LNM-negative group (n = 45) | LNM-positive group (n = 21) | p | OR (95%CI) | p | |
Gender (male/female) | 18/27 | 11/10 | 0.350 | ||
Age, year | 52.87 ± 12.19 | 55.62 ± 12.03 | 0.390 | ||
BMI, kg/m2 | 24.75 ± 3.89 | 24.06 ± 4.40 | 0.520 | ||
Symptom (present or absent) | 23/22 | 11/10 | 0.920 | ||
NLR (mean ± SD) | 2.29 ± 1.39 | 3.02 ± 4.02 | 0.510 | ||
TB (< 21/ ≥ 21), μmol/L | 40/5 | 13/6 | 0.070 | ||
ALT (< 40/ ≥ 40), IU/L | 42/3 | 13/6 | 0.016 | ||
AST (< 40/ ≥ 40), IU/L | 43/2 | 14/7 | 0.003 | ||
FBG (< 6.1/ ≥ 6.1), mmol/L | 30/14 | 10/9 | 0.240 | ||
CEA (< 5/ ≥ 5), ng/ml | 36/5 | 18/1 | 0.650 | ||
CA199 (< 37/ ≥ 37), U/ml | 39/2 | 13/6 | 0.010 | ||
CA724 (< 5.9/ ≥ 5.9), U/ml | 28/1 | 17/0 | > 0.999 | ||
NSE (< 16.3/ ≥ 16.3), ng/ml | 22/9 | 9/6 | 0.510 | ||
Tumor location (head or neck/ body/tail) | 24/12/9 | 10/6/5 | 0.900 | ||
SI on T2WI (hypointense/ isointense/hyperintense) | 2/31/12 | 3/14/4 | 0.360 | ||
Maximum diameter of the tumor (< = 20/ > 20 mm) | 15/30 | 3/18 | 0.106 | ||
Tumor margin (regular/ irregular) | 29/16 | 6/15 | 0.007 | 4.722(1.093–20.404) | 0.038* |
Exophytic growth (present or absent) | 23/22 | 13/8 | 0.410 | ||
MPDD or CBDD (present or absent) | 11/34 | 12/9 | 0.009 | ||
Hyperenhancement at arterial phase (present or absent) | 27/18 | 7/14 | 0.043 | ||
Homogeneity (present or absent) | 33/12 | 9/12 | 0.017 | ||
Vascular and adjacent tissue involvement (present or absent) | 6/39 | 9/12 | 0.012 | ||
Synchronous liver metastases | 7/38 | 11/10 | 0.002 | ||
Long axis of the largest lymph node, mm | 7.44 ± 6.25 | 15.52 ± 6.64 | < 0.001* | ||
Short axis of the largest lymph node, mm | 4.11 ± 3.26 | 10.05 ± 4.93 | < 0.001* | 1.488(1.162–1.907) | 0.002* |
Ratio of the long axis to the short axis of the largest lymph node | 1.87 ± 0.62 | 1.61 ± 0.31 | 0.150 | ||
Irregular shape of the largest lymph node (present or absent) | 3/42 | 10/11 | < 0.001* | ||
Number of the lymph nodes with the short axis > 5 mm | 0.71 ± 0.87 | 2.24 ± 1.70 | < 0.001* | ||
Number of the lymph nodes with the short axis > 10 mm | 0.09 ± 0.42 | 0.95 ± 1.16 | < 0.001* | ||
ADCmean (× 10–3 mm2/s) | 1453.85 ± 314.02 | 1505.07 ± 755.50 | 0.600 | ||
ADCmax (× 10–3 mm2/s) | 2371.39 ± 590.96 | 2917.76 ± 1754.11 | 0.350 | ||
ADCmin (× 10–3 mm2/s) | 574.80 ± 691.29 | 337.94 ± 524.81 | 0.007 | ||
Tumor volume, mm3 | 32,301.35 ± 67,882.65 | 139,198.20 ± 447,799.03 | 0.140 |